And what a conference it was! On 3 – 5 April in Brisbane, we hosted global leaders and experts in the antimicrobial resistance (AMR) space - including researchers, politicians, policymakers and advocates - for the Solutions for Drug-Resistant Infections conference (SDRI 2017).
CO-ADD tests compounds against five of the top pathogens listed on the WHO priority list for R&D of new antibiotics: Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus, as well as the fungi Cryptococcus neoformans and Candida albicans.
“We welcome the published list of priority pathogens to be worked on from the World Health Organization. Our research targets five of the pathogens listed, including the three most critical. This will be a vital tool that will guide antibiotic research and drug discovery for the future,” said CO-ADD Dr Mark Blaskovich.
CO-ADD media enquiries: r.neale1@uq.edu.au; +61 (0) 733462389
Registrations still open for Solutions for Drug-Resistant Infections (SDRI 2017) conference
SDRI 2017 will bring together leading scientific, medical and industry experts to discuss new solutions to the global challenge of drug-resistant pathogens. The conference will take place at the Brisbane Convention and Exhibition Centre in Australia from 3 - 5 April, 2017.
Over the last 6 yrs @CMO_England has been working tirelessly on awareness & action on #AMR. Join #SDRI2017 #Brisbane https://t.co/MF9CuNuUOa pic.twitter.com/fl9dAu0Bea
— SDRI conference (@SDRIconference) January 24, 2017
Superbug-infested waters posed a major health threat to our sporting superstars at this year's Rio Olympic Games. But what did this mean for our athletes? Are athletes more prone to superbug infections? And are antibiotics overprescribed in the sporting world?
Brisbane-based sport and science experts discussed these questions and more during Superbugs at the Olympics on 17 November 2016 during Global Antibiotic Awareness Week.
Royal Brisbane and Women's Hospital (RBWH) Education Centre, Herston, QLD, Australia
Date: 14 November 2016, 9.00am – 7.00pm
Free registration
A joint initiative of The University of Queensland's Institute for Molecular Bioscience Centre for Superbug Solutions, Queensland Health's Communicable Diseases Clinical Network, and Queensland Health's Queensland Statewide Antimicrobial Stewardship Program.
